Boston Scientific ROA 2006-2018 | BSX

Current and historical return on assets (ROA) values for Boston Scientific (BSX) over the last 10 years.
Boston Scientific Annual ROA - Return on Assets
2017 0.55
2016 1.92
2015 -1.32
2014 -0.70
2013 -0.73
2012 -23.72
2011 2.07
2010 -4.81
2009 -4.07
2008 -7.50
2007 -1.59
2006 -11.58
2005 7.66
Boston Scientific Quarterly ROA - Return on Assets
Q2 2018 2.84
Q1 2018 1.55
Q4 2017 -3.23
Q3 2017 1.52
Q2 2017 0.79
Q1 2017 1.62
Q4 2016 0.69
Q3 2016 1.29
Q2 2016 -1.16
Q1 2016 1.14
Q4 2015 -0.78
Q3 2015 -1.09
Q2 2015 0.60
Q1 2015 -0.01
Q4 2014 -1.76
Q3 2014 0.26
Q2 2014 0.02
Q1 2014 0.81
Q4 2013 0.65
Q3 2013 -0.03
Q2 2013 0.77
Q1 2013 -2.11
Q4 2012 0.36
Q3 2012 -3.93
Q2 2012 -20.08
Q1 2012 0.53
Q4 2011 0.50
Q3 2011 0.66
Q2 2011 0.68
Q1 2011 0.21
Q4 2010 1.07
Q3 2010 0.85
Q2 2010 0.43
Q1 2010 -6.95
Q4 2009 -4.27
Q3 2009 -0.36
Q2 2009 0.60
Q1 2009 -0.05
Q4 2008 -8.78
Q3 2008 -0.25
Q2 2008 0.33
Q1 2008 1.06
Q4 2007 -1.47
Q3 2007 -0.87
Q2 2007 0.37
Q1 2007 0.39
Q4 2006 0.90
Q3 2006 0.25
Q2 2006 -13.92
Q1 2006 3.65
Q4 2005 4.08
Q3 2005 -3.33
Q2 2005 2.54
Q1 2005 4.58
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $46.605B $9.048B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $123.073B 19.05
Abbott Laboratories (ABT) United States $111.627B 23.39
Stryker (SYK) United States $62.161B 24.02
Baxter (BAX) United States $37.778B 25.71
Zimmer Biomet Holdings (ZBH) United States $24.903B 16.00
Smith & Nephew SNATS (SNN) United Kingdom $15.491B 0.00
ResMed (RMD) United States $15.453B 30.67
Bio-Rad Laboratories (BIO) United States $9.687B 62.27
Perrigo (PRGO) Ireland $9.503B 13.48
Hill-Rom Holdings (HRC) United States $6.289B 21.33
ICU Medical (ICUI) United States $6.001B 40.67
Canopy Growth (CGC) Canada $5.429B 0.00
Haemonetics (HAE) United States $5.340B 48.73
Insulet (PODD) United States $5.133B 0.00
Agios Pharmaceuticals (AGIO) United States $4.525B 0.00
Neogen (NEOG) United States $4.386B 69.89
Hutchison China MediTech (HCM) China $4.128B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.707B 0.00
NuVasive (NUVA) United States $3.433B 32.57
National Vision Holdings (EYE) United States $3.287B 72.72
Quidel (QDEL) United States $2.771B 56.77
Phibro Animal Health (PAHC) United States $2.014B 29.91
NxStage Medical (NXTM) United States $1.858B 0.00
Cardiovascular Systems (CSII) United States $1.239B 745.00
Eagle Pharmaceuticals (EGRX) United States $1.195B 35.27
VAREX IMAGING (VREX) United States $1.118B 18.26
AtriCure (ATRC) United States $1.092B 0.00
Omeros (OMER) United States $1.001B 0.00
Orthofix (OFIX) United States $1.001B 30.48
OraSure Technologies (OSUR) United States $0.995B 65.08
TG Therapeutics (TGTX) United States $0.977B 0.00
Surmodics (SRDX) United States $0.976B 117.90
Cerus (CERS) United States $0.974B 0.00
Owens & Minor (OMI) United States $0.947B 10.13
MacroGenics (MGNX) United States $0.866B 0.00
LeMaitre Vascular (LMAT) United States $0.707B 33.91
PetIQ (PETQ) United States $0.694B 23.76
Meridian Bioscience (VIVO) United States $0.632B 21.59
Insys Therapeutics (INSY) United States $0.560B 0.00
Evolus (EOLS) United States $0.530B 0.00
Lantheus Holdings (LNTH) United States $0.515B 16.01
NanoString Technologies (NSTG) United States $0.413B 0.00
Cytosorbents (CTSO) United States $0.346B 0.00
BioLife Solutions (BLFS) United States $0.337B 0.00
Utah Medical Products (UTMD) United States $0.335B 21.60
Quanterix (QTRX) United States $0.315B 0.00
Surface Oncology (SURF) United States $0.275B 0.00
Rockwell Medical (RMTI) United States $0.245B 0.00
Chimerix (CMRX) United States $0.202B 0.00
Fonar (FONR) United States $0.170B 10.32
Chembio Diagnostics (CEMI) United States $0.163B 0.00
Bovie Medical (BVX) United States $0.156B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.120B 0.00
Female Health (VERU) United States $0.109B 0.00
Trinity Biotech (TRIB) Ireland $0.091B 27.13
Oramed Pharmaceuticals (ORMP) Israel $0.087B 0.00
United-Guardian (UG) United States $0.086B 18.94
Neurotrope (NTRP) United States $0.077B 0.00
InfuSystems Holdings (INFU) United States $0.076B 0.00
CAS Medical Systems (CASM) United States $0.067B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Capricor Therapeutics (CAPR) United States $0.030B 0.00
Akers Biosciences Inc (AKER) United States $0.028B 0.00
Myomo (MYO) United States $0.025B 0.00
Senestech (SNES) United States $0.017B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Cellectar Biosciences (CLRB) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00